MiMedx Group Inc/ US6024961012 /
2024-04-25 10:00:00 PM | Chg. -0.1850 | Volume | Bid2:25:38 PM | Ask2:25:38 PM | High | Low |
---|---|---|---|---|---|---|
6.2450USD | -2.88% | 1.59 mill. Turnover: 8.61 mill. |
3.2000Bid Size: 200 | 6.4300Ask Size: 200 | 6.3000 | 5.6501 |
GlobeNewswire
04-16
MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30
GlobeNewswire
03-21
TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial R...
GlobeNewswire
02-28
MIMEDX Announces Fourth Quarter and Full Year 2023 Operating and Financial Results
GlobeNewswire
02-12
MIMEDX to Host Fourth Quarter and Full Year 2023 Operating and Financial Results Conference Call on ...
GlobeNewswire
01-26
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, In...
GlobeNewswire
01-26
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages MiMedx Group, Inc. Investors to Inquire About Secur...
Newsfile Corp
01-23
MDXG INVESTOR NOTICE: ROSEN, A LONGSTANDING LAW FIRM, Encourages MiMedx Group, Inc. Investors to Inq...
GlobeNewswire
01-22
MIMEDX Announces Improved Capital Structure with New Senior Secured Credit Facilities and Debt Refin...
GlobeNewswire
01-20
MDXG LOSS ALERT: ROSEN, NATIONAL TRIAL COUNSEL, Encourages MiMedx Group, Inc. Investors to Inquire A...
GlobeNewswire
01-18
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, In...
GlobeNewswire
01-16
MIMEDX ALERT: Bragar Eagel & Squire, P.C. is Investigating MiMedx Group, Inc. on Behalf of MiMedx St...
GlobeNewswire
01-02
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, In...
GlobeNewswire
2023-12-29
MIMEDX Provides AXIOFILL® Update & Reiterates 2023 Full Year Net Sales and Fourth Quarter Adjusted E...
GlobeNewswire
2023-12-28
MIMEDX Announces Conversion of Outstanding Series B Convertible Preferred Stock to Common Stock
GlobeNewswire
2023-12-19
Spectral AI Names Industry Veteran and Former Top MiMedx Financial Executive Peter M. Carlson as CFO